External Advisory Board

External Advisory Board

The External Scientific Advisory Board, which consists of national experts in basic, clinical and population-based research, participates in an annual external scientific review of the Masonic Cancer Center's activities.

External Advisory Board

Kevin Cullen, MD - Chairperson

Director, University of Maryland Greenebaum Cancer Center, Baltimore, MD

Alan Ashworth, PhD, FRS

President, University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Smita Bhatia, MD, MPH

Associate Director for Outcomes Research, University of Alabama Birmingham Comprehensive Cancer Center, Birmingham, AL

Mary-Ann Bjornsti, PhD

Chair of the Department of Pharmacology and Toxicology, the Newman H. Waters Chair of Clinical Pharmacology, Program Leader of Cancer Cell Biology and Associate Director for Translational Research for the O'Neal Comprehensive Cancer Center, Birmingham, AL

Melissa Bondy, PhD

Associate Director for Population Sciences, Stanford Cancer Institute Chair, Department of Epidemiology and Population Health, Stanford Medicine

Stan Gerson, MD

Director, Case Comprehensive Cancer Center, Cleveland, OH

David Horne, PhD

Vice Provost, Beckman Research Institute of The City of Hope, Duarte, CA

Thomas Kensler, PhD

Professor, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Anita Y. Kinney, PhD

Associate Director for Cancer Health Equity and Engagement, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Drew Memmott, Mphil, MA

Associate Director for Administration, University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL

James Mulé, PhD

Associate Center Director, Translational Science & Technology Development, Moffitt Cancer Center, Tampa, FL

Kola S. Okuyemi, MD MPH

Chair of the Department of Family Medicine Associate Dean for Health Equity Research and Implementation, Indiana University School of Medicine

Vito Quaranta, MD

Professor of Biochemistry & Pharmacology Director, Quantitative and Chemical Biology Program Vanderbilt University School of Medicine

Louis Weiner, MD

Director, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC